Our Diversity Edge: Sanofi in 2022
In the first full year of our new People and Culture strategy, Diversity, Equity, and Inclusion (DE&I) took center stage. This report celebrates the tangible progress we’ve made towards reflecting diversity in our leadership, unleashing the full potential of our people, and achieving impact in and beyond the workplace.
Change is about making bold choices and standing by them. In 2022, we launched a new, purpose-driven brand and inaugurated our DE&I Board: the first of its kind in the pharmaceutical industry. It propelled DE&I from aspiration to full integration within the company’s overall strategy by combining the unhindered perspectives of external members-prominent thought leaders in DE&I-alongside members of our Executive Committee and global Employee Resource Groups (ERGs).
We co-created our first-ever global DE&I strategy with representation from all of Sanofi and translated it swiftly into action. One of our most important undertakings in 2022 was ensuring that over 90,000 Sanofians in 65 countries understood the culture change we’re trying to achieve, and how we expect them to play their part.
We hope you will see in this report a company undergoing unprecedented change, and on track to achieving sustainable social impact in and beyond the workplace. With our 2025 goals always in our sights, we will keep fueling the passion of our people to bring the best of their whole selves to an inclusive workplace, where they can deliver outstanding performance and growth.
